No insider purchase over the last 90 days. The latest was filed 10 Jun 2026.
Topchoice Medical Co., Inc. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). Over the twelve months to 18 October 2026, 6 filings were filed, from 3 insiders.
Only purchases show up on the open market, 6 purchases in all worth €268k, filed by 3 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. At €126k, the purchase published on 27 March 2026 by 王毅 is the largest of the period. The buyers include 3 board members.
The data flag 5 purchases as part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The clock since the last published purchase (10 June 2026) now reads 130 days. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. Until a filing is published, the market cannot know about the trade.
Compared with its exchange (515 companies, median 2 filings), a count of 6 filings is above the norm. The full history, which starts in 2022, counts 13 purchases against no sales.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
13 of 13 declarations
通策医疗 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and provision of innovative medical services.